1. Home
  2. HCC vs TMDX Comparison

HCC vs TMDX Comparison

Compare HCC & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Warrior Met Coal Inc.

HCC

Warrior Met Coal Inc.

HOLD

Current Price

$101.00

Market Cap

4.6B

Sector

Energy

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$141.71

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCC
TMDX
Founded
2015
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.2B
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
HCC
TMDX
Price
$101.00
$141.71
Analyst Decision
Buy
Buy
Analyst Count
6
8
Target Price
$76.40
$144.25
AVG Volume (30 Days)
750.1K
660.2K
Earning Date
02-12-2026
02-26-2026
Dividend Yield
0.32%
N/A
EPS Growth
N/A
170.70
EPS
0.67
2.54
Revenue
$1,224,320,000.00
$566,354,000.00
Revenue This Year
N/A
$38.81
Revenue Next Year
$47.01
$20.49
P/E Ratio
$149.58
$56.53
Revenue Growth
N/A
41.20
52 Week Low
$38.00
$55.00
52 Week High
$105.35
$156.00

Technical Indicators

Market Signals
Indicator
HCC
TMDX
Relative Strength Index (RSI) 79.63 63.09
Support Level $86.85 $134.00
Resistance Level $105.35 $151.85
Average True Range (ATR) 3.36 6.57
MACD 0.77 1.73
Stochastic Oscillator 77.05 68.91

Price Performance

Historical Comparison
HCC
TMDX

About HCC Warrior Met Coal Inc.

Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: